Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR)

CUSIP: 04683R106

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
79,671,812
Total 13F shares
56,849,245
Share change
-191,754
Total reported value
$170,555,234
Put/Call ratio
35%
Price per share
$3.00
Number of holders
117
Value change
-$2,209,314
Number of buys
50
Number of sells
60

Security key

04683R106

Report period

Q3 2023

Institutions

117

Top holders

10

Top shareholders of AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
11%
8,497,306
$31,779,924 30 Jun 2023
13F
BlackRock Finance, Inc.
13F
Company
9.7%
7,708,713
$28,830,588 30 Jun 2023
13F
EcoR1 Capital, LLC
13F
Company
8.8%
6,995,861
$26,164,520 30 Jun 2023
13F
VANGUARD GROUP INC
13F
Company
5.7%
4,517,599
$16,895,820 30 Jun 2023
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
3.8%
3,026,455
$11,318,942 30 Jun 2023
13F
Bain Capital Life Sciences Investors, LLC
13F
Company
3.1%
2,485,638
$9,296,286 30 Jun 2023
13F
BML Capital Management, LLC
13F
Company
2.8%
2,236,239
$8,363,534 30 Jun 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.1%
1,645,038
$6,152,442 30 Jun 2023
13F
Cormorant Asset Management, LP
13F
Company
1.9%
1,547,181
$5,786,457 30 Jun 2023
13F
STATE STREET CORP
13F
Company
1.9%
1,533,288
$5,734,497 30 Jun 2023
13F
CITADEL ADVISORS LLC
13F
Company
1.9%
1,481,783
$5,541,868 30 Jun 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.7%
1,363,382
$5,099,000 30 Jun 2023
13F
Tyrus Capital S.A.M.
13F
Company
1.6%
1,260,000
$4,712,400 30 Jun 2023
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
1.3%
996,275
$3,724,000 30 Jun 2023
13F
Stonepine Capital Management, LLC
13F
Company
0.94%
752,088
$2,812,809 30 Jun 2023
13F
NORTHERN TRUST CORP
13F
Company
0.81%
646,743
$2,418,819 30 Jun 2023
13F
FEDERATED HERMES, INC.
13F
Company
0.77%
613,990
$2,296,323 30 Jun 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.72%
573,959
$2,146,607 30 Jun 2023
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.71%
564,772
$2,112,247 30 Jun 2023
13F
SECTORAL ASSET MANAGEMENT INC
13F
Company
0.63%
501,537
$1,875,748 30 Jun 2023
13F
Vontobel Holding Ltd.
13F
Company
0.63%
501,537
$1,875,748 30 Jun 2023
13F
MORGAN STANLEY
13F
Company
0.54%
429,496
$1,606,314 30 Jun 2023
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.48%
379,912
$1,420,871 30 Jun 2023
13F
BANQUE PICTET & CIE SA
13F
Company
0.43%
345,077
$1,290,588 30 Jun 2023
13F
Bank of New York Mellon Corp
13F
Company
0.4%
321,305
$1,201,681 30 Jun 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.38%
305,721
$1,143,397 30 Jun 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.38%
305,285
$1,141,766 30 Jun 2023
13F
Nuveen Asset Management, LLC
13F
Company
0.37%
292,091
$1,092,420 30 Jun 2023
13F
CM Management, LLC
13F
Company
0.31%
250,000
$935,000 30 Jun 2023
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.27%
215,905
$807,485 30 Jun 2023
13F
Invesco Ltd.
13F
Company
0.26%
210,530
$787,383 30 Jun 2023
13F
FIRST TRUST ADVISORS LP
13F
Company
0.26%
203,566
$761,336 30 Jun 2023
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.25%
196,078
$733,000 30 Jun 2023
13F
HRT FINANCIAL LP
13F
Company
0.23%
181,063
$677,000 30 Jun 2023
13F
Auour Investments LLC
13F
Company
0.22%
177,000
$661,980 30 Jun 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.22%
175,180
$655,173 30 Jun 2023
13F
RBF Capital, LLC
13F
Company
0.2%
158,649
$593,497 30 Jun 2023
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.2%
158,100
$591,294 30 Jun 2023
13F
RHUMBLINE ADVISERS
13F
Company
0.18%
141,055
$527,545 30 Jun 2023
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.16%
124,620
$466,079 30 Jun 2023
13F
Acuitas Investments, LLC
13F
Company
0.15%
123,430
$461,628 30 Jun 2023
13F
NEW YORK LIFE INVESTMENT MANAGEMENT LLC
13F
Company
0.15%
123,025
$460,114 30 Jun 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.13%
102,510
$383,388 30 Jun 2023
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.13%
101,587
$380,000 30 Jun 2023
13F
STRS OHIO
13F
Company
0.13%
100,700
$376,000 30 Jun 2023
13F
UBS Group AG
13F
Company
0.12%
98,864
$369,752 30 Jun 2023
13F
Nebula Research & Development LLC
13F
Company
0.12%
97,107
$363,180 30 Jun 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.12%
92,351
$345,393 30 Jun 2023
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.11%
90,068
$301,728 30 Jun 2023
13F
Newtyn Management, LLC
13F
Company
0.11%
89,197
$333,597 30 Jun 2023
13F

Institutional Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q3 2023

As of 30 Sep 2023, Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,849,245 shares. The largest 10 holders included BlackRock Inc., EcoR1 Capital, LLC, FMR LLC, BML Capital Management, LLC, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, Bain Capital Life Sciences Investors, LLC, GEODE CAPITAL MANAGEMENT, LLC, Stonepine Capital Management, LLC, and STATE STREET CORP. This page lists 118 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
131
Q3 2023 holders
117
Holder diff
-14
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .